Home
/
SOLENO THERAPEUTICS INC
/
Financials
/
Quarterly
SOLENO THERAPEUTICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SOLENO THERAPEUTICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2015
Sep 30, 2015
$247.0K
Nov 12, 2015
Q2
2015
Jun 30, 2015
$97.0K
Aug 10, 2015
Q1
2015
Mar 31, 2015
$22.0K
May 4, 2015
Q3
2014
Sep 30, 2013
$3.00M
Dec 18, 2014
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2017
Jun 30, 2017
$1.0K
Aug 11, 2017
Q1
2017
Mar 31, 2017
$265.0K
May 11, 2017
Q3
2016
Sep 30, 2016
$329.0K
Nov 14, 2016
Q2
2017
Jun 30, 2016
$2.0K
Aug 11, 2017
Q1
2017
Mar 31, 2016
$447.0K
May 11, 2017
Q3
2016
Sep 30, 2015
$247.0K
Nov 14, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$26.01M
Nov 4, 2025
Q3
2025
Jun 30, 2025
($4.71M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($4.71M)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($43.77M)
Nov 4, 2025
Q1
2025
Mar 31, 2025
($43.77M)
May 7, 2025
Q2
2025
Mar 31, 2025
($43.77M)
Aug 6, 2025
Q3
2025
Sep 30, 2024
($76.62M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($21.85M)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($21.85M)
Nov 4, 2025
Q3
2025
Mar 31, 2024
($21.40M)
Nov 4, 2025
Q2
2025
Mar 31, 2024
($21.40M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($21.40M)
May 7, 2025
Q3
2024
Sep 30, 2023
($10.86M)
Nov 6, 2024
Q3
2024
Jun 30, 2023
($8.48M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($8.48M)
Aug 7, 2024
Q2
2024
Mar 31, 2023
($8.36M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($8.36M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($8.36M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.13M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($6.73M)
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$22.11M
Nov 4, 2025
Q2
2025
Jun 30, 2025
($6.53M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($45.74M)
May 7, 2025
Q3
2025
Sep 30, 2024
($80.21M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($24.87M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($23.48M)
May 7, 2025
Q3
2024
Sep 30, 2023
($10.38M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($8.62M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($8.47M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.24M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($6.78M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($5.77M)
May 9, 2023
Q3
2022
Sep 30, 2021
($8.29M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($11.09M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($9.16M)
May 10, 2022
Q3
2021
Sep 30, 2020
($7.86M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($11.19M)
Jul 28, 2021
Q1
2021
Mar 31, 2020
($9.28M)
May 5, 2021
Q3
2020
Sep 30, 2019
($6.13M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($5.62M)
Aug 10, 2020